Polydopamine-mediated immobilization of multiple bioactive molecules for the development of functional vascular graft materials

Biomaterials

Volumn 33, Issue 33, 2012, Pages 8343-8352

  Lee, Yu Bin ^a   Shin, Young Min ^a   Lee, Ji hye ^a   Jun, Indong ^a   Kang, Jae Kyeong ^b   Park, Jong Chul ^b   Shin, Heungsoo ^a  

^a Hanyang University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Dual factor immobilization; Endothelialization; Human umbilical vein endothelial cell; Polydopamine coating; Surface modification

Indexed keywords

ADHERENT CELLS; BASIC FIBROBLAST GROWTH FACTOR; BIOACTIVE FACTOR; BIOACTIVE MOLECULES; CAPROLACTONE; CELL-ADHESIVES; ENDOTHELIALIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCAMINES; FUNCTIONALIZED; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; POLYDOPAMINE; POLYDOPAMINE COATING; RGD PEPTIDE; SIMPLE METHOD; TIME-DEPENDENT; VASCULAR GRAFTS; VON WILLEBRAND FACTOR;

BIOACTIVITY; COATINGS; ENDOTHELIAL CELLS; GRAFTS; LACTIC ACID; PEPTIDES; SURFACE TREATMENT;

FILM PREPARATION;

FIBROBLAST GROWTH FACTOR; POLY(LACTIC ACID CO 3 CAPROLACTONE); POLYMER; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ARTICLE; BLOOD VESSEL GRAFT; CELL ADHESION; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMOBILIZATION; LONG TERM CARE; PRIORITY JOURNAL; UMBILICAL VEIN ENDOTHELIAL CELL;

HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INDOLES; POLYESTERS; POLYMERS; VASCULAR GRAFTING;

EID: 84866143543     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.08.011     Document Type: Article

References (43)

1. Bordenave L., Menu P., Baquey C. Developments towards tissue-engineered, small-diameter arterial substitutes. Expert Rev Med Devices 2008, 5:337-347.
2. Kannan R.Y., Salacinski H.J., Sales K., Butler P., Seifalian A.M. The roles of tissue engineering and vascularisation in the development of micro-vascular networks: a review. Biomaterials 2005, 26:1857-1875.
3. de Mel A., Jell G., Stevens M.M., Seifalian A.M. Biofunctionalization of biomaterials for accelerated in situ endothelialization: a review. Biomacromolecules 2008, 9:2969-2979.
4. Caiado F., Carvalho T., Silva F., Castro C., Clode N., Dye J.F., et al. The role of fibrin E on the modulation of endothelial progenitors adhesion, differentiation and angiogenic growth factor production and the promotion of wound healing. Biomaterials 2011, 32:7096-7105.
5. Whelan M.C., Senger D.R. Collagen I initiates endothelial cell morphogenesis by inducing actin polymerization through suppression of cyclic AMP and protein kinase A. J Biol Chem 2003, 278:327-334.
6. Ingber D.E. Fibronectin controls capillary endothelial cell growth by modulating cell shape. Proc Natl Acad Sci U S A 1990, 87:3579-3583.
7. Isik F.F., Gibran N.S., Jang Y.C., Sandell L., Schwartz S.M. Vitronectin decreases microvascular endothelial cell apoptosis. J Cell Physiol 1998, 175:149-155.
8. Lovett M., Lee K., Edwards A., Kaplan D.L. Vascularization strategies for tissue engineering. Tissue Eng Part B Rev 2009, 15:353-370.
9. Carey D.J. Control of growth and differentiation of vascular cells by extracellular matrix proteins. Annu Rev Physiol 1991, 53:161-177.
10. Barker T.H. The role of ECM proteins and protein fragments in guiding cell behavior in regenerative medicine. Biomaterials 2011, 32:4211-4214.
11. Lamalice L., Le Boeuf F., Huot J. Endothelial cell migration during angiogenesis. Circ Res 2007, 100:782-794.
12. Koch S., Yao C., Grieb G., Prevel P., Noah E.M., Steffens G.C. Enhancing angiogenesis in collagen matrices by covalent incorporation of VEGF. J Mater Sci Mater Med 2006, 17:735-741.
13. Saik J.E., Gould D.J., Watkins E.M., Dickinson M.E., West J.L. Covalently immobilized platelet-derived growth factor-BB promotes angiogenesis in biomimetic poly(ethylene glycol) hydrogels. Acta Biomater 2011, 7:133-143.
14. Cottam E., Hukins D.W., Lee K., Hewitt C., Jenkins M.J. Effect of sterilisation by gamma irradiation on the ability of polycaprolactone (PCL) to act as a scaffold material. Med Eng Phys 2009, 31:221-226.
15. Nagai M., Hayakawa T., Makimura M. Fibronectin immobilization using water-soluble carbodiimide on poly-L-lactic acid for enhancing initial fibroblast attachment. J Biomater Appl 2006, 21:33-47.
16. Xia Y., Boey F., Venkatraman S.S. Surface modification of poly(l-lactic acid) with biomolecules to promote endothelialization. Biointerphases 2010, 5:FA32-40.
17. Hsu S.H., Chuang S.C., Chen C.H., Chen D.C. Endothelial cell attachment to the gamma irradiated small diameter polyurethane vascular grafts. Biomed Mater Eng 2006, 16:397-404.
18. Vallieres K., Petitclerc E., Laroche G. Covalent grafting of fibronectin onto plasma-treated PTFE: influence of the conjugation strategy on fibronectin biological activity. Macromol Biosci 2007, 7:738-745.
19. Morra M. Biochemical modification of titanium surfaces: peptides and ECM proteins. Eur Cell Mater 2006, 12:1-15.
20. Nystrom D., Malmstrom E., Hult A., Blakey I., Boyer C., Davis T.P., et al. Biomimetic surface modification of honeycomb films via a "grafting from" approach. Langmuir 2010, 26:12748-12754.
21. Lee H., Dellatore S.M., Miller W.M., Messersmith P.B. Mussel-inspired surface chemistry for multifunctional coatings. Science 2007, 318:426-430.
22. Lynge M.E., van der Westen R., Postma A., Stadler B. Polydopamine - a nature-inspired polymer coating for biomedical science. Nanoscale 2011, 3:4916-4928.
23. Jeong S.I., Kim S.H., Kim Y.H., Jung Y., Kwon J.H., Kim B.S., et al. Manufacture of elastic biodegradable PLCL scaffolds for mechano-active vascular tissue engineering. J Biomater Sci Polym Ed 2004, 15:645-660.
24. Jeong S.I., Jun I.D., Choi M.J., Nho Y.C., Lee Y.M., Shin H. Development of electroactive and elastic nanofibers that contain polyaniline and poly(l-lactide-co-epsilon-caprolactone) for the control of cell adhesion. Macromol Biosci 2008, 8:627-637.
25. Jung J.P., Jones J.L., Cronier S.A., Collier J.H. Modulating the mechanical properties of self-assembled peptide hydrogels via native chemical ligation. Biomaterials 2008, 29:2143-2151.
26. Kim T.G., Park T.G. Biomimicking extracellular matrix: cell adhesive RGD peptide modified electrospun poly(d, l-lactic-co-glycolic acid) nanofiber mesh. Tissue Eng 2006, 12:221-233.
27. Shen H., Hu X., Yang F., Bei J., Wang S. Cell affinity for bFGF immobilized heparin-containing poly(lactide-co-glycolide) scaffolds. Biomaterials 2011, 32:3404-3412.
28. Shen H., Hu X., Bei J., Wang S. The immobilization of basic fibroblast growth factor on plasma-treated poly(lactide-co-glycolide). Biomaterials 2008, 29:2388-2399.
29. Kaneko T., Fujii S., Matsumoto A., Goto D., Makita N., Hamada J., et al. Induction of tissue factor expression in endothelial cells by basic fibroblast growth factor and its modulation by fenofibric acid. Thromb J 2003, 1:6.
30. Poh C.K., Shi Z., Lim T.Y., Neoh K.G., Wang W. The effect of VEGF functionalization of titanium on endothelial cells in vitro. Biomaterials 2010, 31:1578-1585.
31. Jeong K.J., Wang L.Q., Stefanescu C.F., Lawlor M.W., Polat J., Dohlman C.H., et al. Polydopamine coatings enhance biointegration of a model polymeric implant. Soft Matter 2011, 7:8305-8312.
32. Risau W. Differentiation of endothelium. FASEB J 1995, 9:926-933.
33. Shin Y.M., Lee Y.B., Shin H. Time-dependent mussel-inspired functionalization of poly(l-lactide-co-varepsilon-caprolactone) substrates for tunable cell behaviors. Colloids Surf B Biointerfaces 2011, 87:79-87.
34. Ku S.H., Park C.B. Human endothelial cell growth on mussel-inspired nanofiber scaffold for vascular tissue engineering. Biomaterials 2010, 31:9431-9437.
35. Gao C.Y., Guan J.J., Zhu Y.B., Shen J.C. Surface immobilization of bioactive molecules on polyurethane for promotion of cytocompatibility to human endothelial cells. Macromol Biosci 2003, 3:157-162.
36. Kim M.S., Bhang S.H., Yang H.S., Rim N.G., Jun I., Kim S.I., et al. Development of functional fibrous matrices for the controlled release of basic fibroblast growth factor to improve therapeutic angiogenesis. Tissue Eng Part A 2010, 16:2999-3010.
37. Hersel U., Dahmen C., Kessler H. RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials 2003, 24:4385-4415.
38. Wacker B.K., Alford S.K., Scott E.A., Das Thakur M., Longmore G.D., Elbert D.L. Endothelial cell migration on RGD-peptide-containing PEG hydrogels in the presence of sphingosine 1-phosphate. Biophys J 2008, 94:273-285.
39. Vitorino P., Meyer T. Modular control of endothelial sheet migration. Genes Dev 2008, 22:3268-3281.
40. Choi W.S., Bae J.W., Lim H.R., Joung Y.K., Park J.C., Kwon I.K., et al. RGD peptide-immobilized electrospun matrix of polyurethane for enhanced endothelial cell affinity. Biomed Mater 2008, 3:044104.
41. Privratsky J.R., Paddock C.M., Florey O., Newman D.K., Muller W.A., Newman P.J. Relative contribution of PECAM-1 adhesion and signaling to the maintenance of vascular integrity. J Cell Sci 2011, 124:1477-1485.
42. Baruch D., Denis C., Marteaux C., Schoevaert D., Coulombel L., Meyer D. Role of von Willebrand factor associated to extracellular matrices in platelet adhesion. Blood 1991, 77:519-527.
43. McGrath R.T., McRae E., Smith O.P., O'Donnell J.S. Platelet von Willebrand factor-structure, function and biological importance. Br J Haematol 2010, 148:834-843.